| Materials Science | Lifetime | 961 | SG 16 | 99.55 |
| Biological Sciences | 2021-2025 | 453 | SG 2 | 99.52 |
| Biomedical Engineering | Lifetime | 29 | SG 2 | 99.94 |
| Materials Chemistry | Lifetime | 467 | SG 9 | 99.52 |
| Biomedical Engineering | 2021-2025 | 18 | SG 2 | 99.93 |
| Molecular Biology | 2021-2025 | 207 | SG 1 | 99.13 |
| Immunology | 2021-2025 | 88 | SG 1 | 98.37 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 397 | SG 2 | 95.91 |
| Nanoplatforms for cancer theranostics | Lifetime | 10 | SG 1 | 99.95 |
| Photodynamic Therapy Research Studies | Lifetime | 4 | SG 1 | 99.75 |
| Luminescence and Fluorescent Materials | Lifetime | 14 | SG 1 | 99.89 |
| Photoacoustic and Ultrasonic Imaging | Lifetime | 10 | SG 1 | 99.85 |
| Advanced biosensing and bioanalysis techniques | Lifetime | 135 | SG 2 | 99.60 |
| Extracellular vesicles in disease | Lifetime | 53 | SG 2 | 99.24 |
| Advanced Nanomaterials in Catalysis | Lifetime | 75 | SG 2 | 99.51 |
| Cancer, Stress, Anesthesia, and Immune Response | Lifetime | 61 | SG 1 | 97.77 |
| Molecular Sensors and Ion Detection | Lifetime | 294 | SG 1 | 98.54 |
| Immune cells in cancer | Lifetime | 429 | SG 2 | 97.66 |
| Nanoparticle-Based Drug Delivery | Lifetime | 465 | SG 6 | 98.13 |
| Dendrimers and Hyperbranched Polymers | Lifetime | 171 | SG 2 | 97.24 |
| Ultrasound and Hyperthermia Applications | Lifetime | 895 | SG 3 | 93.53 |
| Sulfur Compounds in Biology | Lifetime | 930 | SG 5 | 90.89 |
| Nanoplatforms for cancer theranostics | 2021-2025 | 6 | SG 1 | 99.96 |
| Photodynamic Therapy Research Studies | 2021-2025 | 4 | SG 1 | 99.71 |
| Cancer, Stress, Anesthesia, and Immune Response | 2021-2025 | 2 | SG 1 | 99.51 |
| Immunotherapy and Immune Responses | 2021-2025 | 25 | SG 2 | 99.51 |
| Immune cells in cancer | 2021-2025 | 35 | SG 2 | 98.83 |
| Photoacoustic and Ultrasonic Imaging | 2021-2025 | 34 | SG 2 | 97.92 |
| Click Chemistry and Applications | 2021-2025 | 33 | SG 2 | 97.42 |
| Luminescence and Fluorescent Materials | 2021-2025 | 114 | SG 1 | 98.61 |
| Extracellular vesicles in disease | 2021-2025 | 177 | SG 2 | 96.72 |
| Ubiquitin and proteasome pathways | 2021-2025 | 131 | SG 1 | 94.20 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 248 | SG 1 | 94.05 |
| Nanoparticle-Based Drug Delivery | 2021-2025 | 209 | SG 1 | 96.20 |
| Advanced biosensing and bioanalysis techniques | 2021-2025 | 614 | SG 3 | 96.68 |
| Advanced Biosensing Techniques and Applications | 2021-2025 | 43 | SG 1 | 93.53 |
| Protein Degradation and Inhibitors | 2021-2025 | 363 | SG 3 | 92.66 |
| Ultrasound and Hyperthermia Applications | 2021-2025 | 246 | SG 2 | 89.89 |
| Peptidase Inhibition and Analysis | 2021-2025 | 749 | SG 4 | 88.18 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | 2021-2025 | 230 | SG 2 | 86.12 |
| Photoreceptor and optogenetics research | 2021-2025 | 789 | SG 10 | 82.53 |
| bioluminescence and chemiluminescence research | 2021-2025 | 109 | SG 1 | 81.78 |
| Inhalation and Respiratory Drug Delivery | 2021-2025 | 781 | SG 2 | 76.95 |
